111 results
Page 4 of 6
424B5
y8ndf0
22 Jan 19
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
o2tivc ukexh
16 Jan 19
Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
5:25pm
424B5
zcdukvu evdben
16 Jan 19
Prospectus supplement for primary offering
5:23pm
424B5
qae0t18we0bdpow4 zd
14 Jan 19
Prospectus supplement for primary offering
4:03pm
8-K
EX-99.1
mly6gp
3 Dec 18
Regulation FD Disclosure
4:29pm
8-K
EX-99.1
x6nh7lt a8
15 Nov 18
Bio-path Holdings Reports Third Quarter 2018 Financial Results
7:05am
8-K
69x32wqa74pm
2 Nov 18
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
4:34pm
8-K
EX-99.1
4kj fc6dygd
2 Nov 18
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
4:34pm
8-K
EX-10.1
7zyaj2mu16gp
21 Sep 18
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
terl4op k5h5
16 Aug 18
Bio-Path Holdings Appoints Dr. Jason B. Fleming to Scientific Advisory Board
1:04pm
8-K
EX-99.1
6nla9
10 May 18
Bio-Path Holdings Appoints Dr. Anas Younes to Scientific Advisory Board
5:02pm